Avantor (AVTR) is back in focus after a sharp Q3 share price move that coincided with renewed organic momentum in its VWR distribution arm and improving Bioprocessing order patterns.
Over the past quarter, Avantor has shifted from a rebuilding story to one where price momentum is clearly building, with a 90 day share price return of 49.9% and a year to date share price gain of 49.7%. This contrasts with a 5 year total shareholder return that remains down 55.2%.
Scan how Avantor's rebound compares with other turnaround stories by reviewing the hand picked 20 high quality undiscovered gems now back on investors' radar.
Avantor has already delivered a near 50% rebound in 90 days, yet the shares still sit well below their 5 year peak. Is the recent surge most of the rerating, or is it just the opening move on valuation?
Most Popular Narrative: 11% Overvalued
Avantor closed at $17.15, which sits above the most followed fair value estimate of $15.46 that is based on a discount rate of 8.77%. That gap frames the current rebound as a market already baking in a successful turnaround rather than waiting for more proof.
The numbers and current valuation together imply a stock price that already reflects a fair outcome where Avantor delivers on its multi year turnaround and free cash flow targets without needing a sharp re rating from here.
See why 10 investors see Avantor as 11% overvalued.
Result: Fair Value of $15.46 (OVERVALUED)
Still, Avantor’s turnaround script can change quickly if competitive pressure in lab distribution persists or if weak funding in biotech and academia keeps organic demand subdued.
Find out about the key risks to this Avantor narrative.
Another View: Avantor Through The Sales Lens
The DCF work suggests Avantor is roughly in line with fair value, yet the market is pricing the stock at a P/S of 1.8x against an industry level of 4.9x and a fair ratio of 3.6x. That gap points to either a value cushion or a quality discount. Which side do you think it reflects?
To pressure test this alternative lens on Avantor, take a closer look at how the numbers stack up against peers and the fair ratio via See what the numbers say about this price — find out in our valuation breakdown..
Next Steps
Sentiment on Avantor is split, which is exactly when fresh data can be most useful for you. Move quickly, review both the red flags and the upside, then weigh the 3 key rewards and 1 important warning sign.
Looking For More Investment Ideas Beyond Avantor?
Avantor's setup is interesting, but your watchlist should not hinge on a single turnaround. Broaden your opportunity set now, before the next move gets away.
- Target resilient balance sheets by scanning a curated list of solid balance sheet and fundamentals (26 results) that aims to surface businesses with financial strength at the core of their story.
- Hunt for mispriced quality through the 30 high quality undervalued stocks and line up candidates where fundamentals and market expectations appear out of sync.
- Lock in income ideas using the 6 dividend fortresses and focus on companies offering higher yields supported by durable cash generation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com